Log In
Print this Print this

Pumactant (Zofac) (AP0016)

  Manage Alerts
Collapse Summary General Information
Company Stada Arzneimittel AG
DescriptionInhaled dry powder containing a mixture of 2 naturally occurring phospholipids
Molecular Target
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today